PMGC Holdings (ELAB) Asset Utilization Ratio (2023 - 2026)
PMGC Holdings (ELAB) posted Asset Utilization Ratio of 0.07 for Q1 2026, up 22.47% sequentially from 0.05 in Q4 2025, and down 70.84% YoY from 0.22 in Q1 2025.
PMGC Holdings (ELAB) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
PMGC Holdings has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.07 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 70.84% year-over-year to 0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07 (down 70.84% YoY) and the FY2025 annual result came in at 0.05, down 84.48% from the prior year.
- Asset Utilization Ratio rose to 0.07 in Q1 2026 per ELAB's latest filing, from 0.05 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.53 in Q2 2024 and troughed at 0.0 in Q4 2023.
- A 4-year average of 0.21 and a median of 0.19 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio jumped 11227.83% in 2024, then sank 78.14% in 2025.
- Over 4 years, Asset Utilization Ratio stood at 0.0 in 2023, then surged by 11227.83% to 0.24 in 2024, then tumbled by 78.14% to 0.05 in 2025, then grew by 22.47% to 0.07 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.07, 0.05, and 0.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.13 |
| 10 | PMGC Holdings | 30.48 Mn | 11.69 Mn | 385,691.00 | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.00 |